CA2286261A1 - Antagonistes retinoides pour la prevention d'adherences necessitant une intervention chirurgicale - Google Patents

Antagonistes retinoides pour la prevention d'adherences necessitant une intervention chirurgicale Download PDF

Info

Publication number
CA2286261A1
CA2286261A1 CA002286261A CA2286261A CA2286261A1 CA 2286261 A1 CA2286261 A1 CA 2286261A1 CA 002286261 A CA002286261 A CA 002286261A CA 2286261 A CA2286261 A CA 2286261A CA 2286261 A1 CA2286261 A1 CA 2286261A1
Authority
CA
Canada
Prior art keywords
carbons
alkyl
group
phenyl
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002286261A
Other languages
English (en)
Inventor
Kenneth M. Tramposch
Xina Nair
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2286261A1 publication Critical patent/CA2286261A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Selon l'invention, certains antagonistes rétinoïdes sont efficaces pour prévenir ou réduire au minimum la formation d'une adhérence nécessitant une intervention chirurgicale.
CA002286261A 1997-04-11 1998-04-09 Antagonistes retinoides pour la prevention d'adherences necessitant une intervention chirurgicale Abandoned CA2286261A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4352897P 1997-04-11 1997-04-11
US5075197P 1997-06-25 1997-06-25
US60/050,751 1997-06-25
US60/043,528 1997-06-25
PCT/US1998/007060 WO1998046223A1 (fr) 1997-04-11 1998-04-09 Antagonistes retinoides pour la prevention d'adherences necessitant une intervention chirurgicale

Publications (1)

Publication Number Publication Date
CA2286261A1 true CA2286261A1 (fr) 1998-10-22

Family

ID=26720518

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002286261A Abandoned CA2286261A1 (fr) 1997-04-11 1998-04-09 Antagonistes retinoides pour la prevention d'adherences necessitant une intervention chirurgicale

Country Status (5)

Country Link
EP (1) EP1005340A4 (fr)
JP (1) JP2001524082A (fr)
AU (1) AU723146B2 (fr)
CA (1) CA2286261A1 (fr)
WO (1) WO1998046223A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6713515B2 (en) 2000-09-13 2004-03-30 Bristol Myers Squibb Company Retinoic acid receptor antagonists as promoters of angiogenesis
FR2847167A1 (fr) * 2002-11-15 2004-05-21 Galderma Res & Dev UTILISATION D'UN ANTAGONISTE DES RECEPTEURS RARs POUR POTENTIALISER L'ACTION DU TGFb
AU2003302070A1 (en) * 2002-11-15 2004-06-15 Galderma Research And Development, S.N.C. USE OF AN RAR RECEPTOR ANTAGONIST FOR POTENTIATING THE ACTION OF TGFBeta

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648385A (en) * 1994-01-03 1997-07-15 Bristol-Myers Squibb Co. Retinoid-like compounds
US5534261A (en) * 1995-01-17 1996-07-09 University Of Southern California Retinoid-based compositions and method for preventing adhesion formation using the same
FR2731706B1 (fr) * 1995-03-14 1997-04-11 Cird Galderma Composes heterocycliques aromatiques, compositions pharmaceutiques et cosmetiques les contenant et utilisations

Also Published As

Publication number Publication date
AU7105398A (en) 1998-11-11
WO1998046223A1 (fr) 1998-10-22
EP1005340A4 (fr) 2001-02-07
AU723146B2 (en) 2000-08-17
EP1005340A1 (fr) 2000-06-07
JP2001524082A (ja) 2001-11-27

Similar Documents

Publication Publication Date Title
DE60214718T2 (de) Verbindungen mit taxol-verstärkender wirkung
DE69920497T2 (de) Liponsaürederivate und deren verwendung bei der behandlung von krankheiten
DE69732049T2 (de) Pharmazeutische zubereitungen, enthaltend salze von hyaluronsäure und lokalanästhetika
AU622276B2 (en) Medicament containing dihydrolipoic acid as active substance
BRPI0409314A (pt) derivados de 2-aminopirimidina e seu uso médico
KR100598451B1 (ko) 동맥 혈전증의 치료와 예방을 위한 조성물과 그 조성물 단독 및/또는 혈소판 응집방지제와 결합한 인자 Ｘａ 억제제의 사용
AU2005314023A1 (en) Pharmaceutical formulations cytidine analogs and derivatives
JPH06511513A (ja) 水溶性の高いシクロデキストリン誘導体及びその使用
HRP20150056T1 (hr) Soli clopidogrela i postupak pripreme
BG108299A (bg) Фармацевтично активни уридинови естери
DE68928551T2 (de) Oculare hypotensive Mittel
ES2214635T3 (es) Uso de compuestos de quelatos de 3-hidroxi-4-pirona para el tratamiento de enfermedades que pueden mejorar inhibiendo la hiperproliferacion de queratinocitos.
FI92198B (fi) Menetelmä valmistaa farmakologisesti arvokkaita 2-(RS)-substituoituja 2,3-dihydro-5-oksi-4,6,7-trimetyylibentsofuraaneja
CA2286261A1 (fr) Antagonistes retinoides pour la prevention d'adherences necessitant une intervention chirurgicale
ID26972A (id) TIOESTER ASAM S-SUBSTITUSI 11β-BENZALDOKSIN ESTRA-4,9-DIENAKARBONAT, PROSES UNTUK MEMBUAT DAN SEDIAAN FARMASI YANG TERDIRI DARI SENYAWA INI
CA2792913A1 (fr) Formule aqueuse stable amelioree de (e)-4-carboxystyryl-4-chlorobenzyl sulfone
CN103384522B (zh) 咖啡酸衍生物和它们在改善神经细胞生存力中的用途
DE60025644T2 (de) Hemmer für das 20-hete-produzierende enzym
JPH06510042A (ja) ロイコトリエンレセプター拮抗剤−抗ヒスタミン剤複合体
DE4327462A1 (de) Neue N-Acetyl-p-Aminophenol-Derivate zur Bekämpfung von Schmerzzuständen
US6319948B2 (en) Retinoid antagonists and uses thereof
CN1178895C (zh) 萘普生前药及其合成方法与应用
WO1988009788A1 (fr) Medicaments pour application locale pour le traitement de l'acne et des affections cutanees
FR2677650B1 (fr) Retinouides substitues par un cycle dithiane et leur utilisation, procede de preparation desdits composes, compositions cosmetique et pharmaceutique les contenant et utilisation therapeutique de cette derniere.
JPH06279432A (ja) 新規な化合物および該化合物を有効成分とする抗癌剤

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead